Clinical Trial Update: Phase II Study of Tin Mesoporphyrin vs Phototherapy for Hyperbilirubinemia in Premature Newborns [Phase 2]

View source ↗

Summary

This Phase II clinical trial evaluating tin mesoporphyrin versus phototherapy for hyperbilirubinemia in premature newborns has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperbilirubinemia

Drugs mentioned

• Tin Mesoporphyrin (tin mesoporphyrin)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Hyperbilirubinemia | Phase 2 | Status: COMPLETED